CureDM, Inc. is actively seeking a partnership to most effectively commercialize our Phase 2 ready compound, HIP2B.

If you are interested in discussing partnering or licensing opportunities with CureDM, Inc., please contact us directly at at 505-515-1947 or Lori@CureDM.com.

Click here for the Partner login page.